Transcarent Revenue and Competitors
Estimated Revenue & Valuation
- Transcarent's estimated annual revenue is currently $66.1M per year.
- Transcarent's estimated revenue per employee is $177,800
- Transcarent's current valuation is $1.6B. (January 2022)
Employee Data
- Transcarent has 372 Employees.
- Transcarent grew their employee count by 18% last year.
Transcarent Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $203M | 1014 | -20% | $65M | N/A |
#2 | $33.4M | 217 | 2% | N/A | N/A |
#3 | $45M | 299 | -4% | $102.6M | N/A |
#4 | $3.2M | 30 | -25% | $21.3M | N/A |
#5 | $34M | 226 | 0% | $42.9M | N/A |
#6 | $3.6M | 34 | -28% | $35M | N/A |
#7 | $0.8M | 10 | N/A | N/A | N/A |
#8 | $12.6M | 90 | -9% | N/A | N/A |
#9 | $17.4M | 124 | 0% | $96.4M | N/A |
#10 | $7.9M | 65 | 18% | $75.6M | N/A |
What Is Transcarent?
Transcarent is a stealth-stage startup in digital health space. Coming soon!
keywords:N/AN/A
Total Funding
372
Number of Employees
$66.1M
Revenue (est)
18%
Employee Growth %
$1.6B
Valuation
N/A
Accelerator
Transcarent News
Transcarent Oncology Care aims to offer an end-to-end solution to better ... chief operating officer at Transcarent, told Fierce Healthcare.
In addition to leading Transcarent, a platform used by employees of self-insured companies to more easily access care, Tullman previously...
Transcarent, a health tech company for self-insured employers, announced a new program focused on the cancer-care space.
Transcarent offers a consumer-directed health and care experience for employees Vator · Interview with Bipin Mistry, Chief Medical Officer at Transcarent Steven Loeb and Bambi Francisco interview Bipin Mistry, Chief Medical Officer at Transcarent, a company that offers a consumer-directed heal ...
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $67.4M | 372 | 3% | N/A |
#2 | $61.4M | 372 | -26% | $1.6M |
#3 | $67.4M | 372 | 79% | N/A |
#4 | $66.3M | 373 | -4% | $19.2M |
#5 | $61.6M | 373 | -7% | $161.3M |